We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bellevue Healthcare Trust Plc | LSE:BBH | London | Ordinary Share | GB00BZCNLL95 | RED ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.00 | 0.71% | 141.40 | 141.20 | 142.40 | 142.00 | 140.00 | 141.00 | 678,939 | 15:50:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | -107.16M | -121.04M | -0.2617 | -5.40 | 654.1M |
TIDMBBH
RNS Number : 4631N
Bellevue Healthcare Trust PLC
20 January 2023
Bellevue Healthcare Trust plc Transactions in own shares Bellevue Healthcare Trust plc (the "Company") announces that today it purchased the following number of its ordinary shares of 1 penny each on the London Stock Exchange through J.P. Morgan Securities plc. Date of purchase: 20 January 2023 Number of ordinary shares purchased: 143,514 Lowest price paid per share 163.60p Highest price paid per share 164.00p Trading venue LSE Average price paid per share: 163.89p The Company intends to hold the purchased shares in treasury. Following the above transaction, the Company holds 4,909,001 of its ordinary shares in treasury and has 551,296,532 ordinary shares in issue (excluding treasury shares). The Company's LEI is: 213800HQ3J3H9YF2UI82 Enquiries: Bellevue Asset Management (UK) Ltd. Mark Ghahramani Telephone: +44 (0) 203 326 2981 J.P. Morgan Cazenove James Bouverat (Sales) Telephone: +44 (0) 207 134 2224 Alvarium Securities Limited Mark Thompson +44 (0)20 7016 6711 Eddie Nissen +44 (0)20 7016 6713 Oliver Kenyon +44 (0)20 7195 1448 Apex Listed Companies Services (UK) Limited Brian Smith / Ciara McKillop Telephone: +44 (0)20 3327 9720
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSFLFVDLFIIFIV
(END) Dow Jones Newswires
January 20, 2023 12:33 ET (17:33 GMT)
1 Year Bellevue Healthcare Chart |
1 Month Bellevue Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions